Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00019955 · ClinicalTrials.gov registry record · Phase 2
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00019955: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00019955 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00019955, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiofrequency interstitial tissue ablation may kill tumor cells by heating tumors to several degrees above body temperature. PURPOSE: This phase II trial is studying radiofrequency interstitial tissue ablation to see how well it works in treating patients with localized renal cell carcinoma (kidney cancer).
Interventions
- PROCEDURE laparoscopic surgery
- PROCEDURE radiofrequency ablation
- PROCEDURE thermal ablation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00019955
The ClinicalTrials.gov registry entry for NCT00019955 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laparoscopic surgery is the first listed.
NCT00019955 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00019955 about?
NCT00019955 is a clinical study titled "Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)". RATIONALE: Radiofrequency interstitial tissue ablation may kill tumor cells by heating tumors to several degrees above body temperature. PURPOSE: This phase II trial is studying radiofrequency interstitial tissue ablation to see how well it works in treating patients with localized renal cell carci...
What is the current status of trial NCT00019955?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-03.
What interventions are being tested in trial NCT00019955?
The interventions under investigation include: laparoscopic surgery (PROCEDURE), radiofrequency ablation (PROCEDURE), thermal ablation therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00019955?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.